Zhijun Wang

North China University of Science and Technology — China

Computer Science · Physical Sciences

7h-index253citations77works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Caching and Content Delivery(5), Cloud Computing and Resource Management(4), Smart Agriculture and AI(4), Topological Materials and Phenomena(3), Food Supply Chain Traceability(3)

Publications77 total

Research on braking energy recovery performance of electric commercial vehicles
2026
Boosting Solar Water Splitting via Spatial Carrier Separation on Bismuth Vanadate Photoanodes
Langmuir·2026
Research on Robot Collision Response Based on Human–Robot Collaboration
Sensors·2026Open Access
Functional design and implementation of the CiADS power supply master controller based on System-on-Chip
Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment·2026
TCPhole: Bringing high-performance TCP/IP to multi-tenant cloud environments via user-space stacks
2025Open Access
Supplementary Figure S3 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Figure S6 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Table S6 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Table S4 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Figure S1 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Table S1 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Figure S4 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Figure S5 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Figure S2 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Table S8 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Table S2 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Table S3 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Data from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Table S7 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
Supplementary Figure S7 from SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
2025Open Access
page 1 of 4Next →

Frequent Co-authors

Li‐Min Wang(6), Changyong Yang(6), Xing Sun(6), Yunan Tian(6), Jieqiong Zhang(6), Lei Zhou(6), Yuan Lin(6), Tingting Wu(6), Wei Zhang(6), Jiayi Li(6), Cheng Liao(6), Peng Lan(5), Hao Che(5), Hong Jiang(5), Bo Sun(3), Shuhan Cheng(3), Dongjian Shen(3), Fang Zhong(3), Xue Wang(3), Jincheng Wang(2)